Hetvi Shah

5PUBLICATIONS
13CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Genetically modified horticulture plants
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 15, 2026
Exogenous Kisspeptin-10 inhibits ovarian cancer progression through targeting the SP1-hTERT-ZEB1 regulatory axis.

|Nov 19, 2025
Early-life macronutrient exposure alters pubertal timing through hypothalamic microRNA networks.

Harsh Shah, Sripriya Bulusu, Hetvi Shah

|Oct 08, 2025
Exogenous kisspeptin-10 treatment shows pleiotropy via induction of KISS1 expression, metastasis suppression, and promotes apoptosis in triple-negative breast cancer.

Hetvi Shah, Adikrishna Murali Mohan, Lipi Buch

|Sep 05, 2025
Deciphering protein-DNA interactions of KISS1 with transcription factors through molecular docking, molecular dynamics simulations, and gene expression analysis.

Hetvi Shah, Pranav Pillai, Lipi Buch

|Feb 12, 2025
De novo Transcriptomic analysis to unveil the deltamethrin induced resistance mechanisms in Callosobruchus chinensis (L.).

Pankaj Sharma, Ankita Salunke, Nishi Pandya

Pageof 1

Frequent Collaborators

5 joint publications

Parth Pandya

3 joint publications

A V Ramachandran

2 joint publications

Ankita Salunke

2 joint publications

Lipi Buch